4//SEC Filing
Smither John W 4
Accession 0001209191-23-059940
CIK 0001801777other
Filed
Dec 27, 7:00 PM ET
Accepted
Dec 28, 5:38 PM ET
Size
10.4 KB
Accession
0001209191-23-059940
Insider Transaction Report
Form 4
Smither John W
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2023-12-27−60,000→ 0 totalExercise: $8.01Exp: 2032-01-27→ Common Stock (60,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-12-27−20,000→ 0 totalExercise: $0.34Exp: 2033-06-14→ Common Stock (20,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2022-05-24−20,000→ 0 totalExercise: $3.13Exp: 2033-05-24→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]Pursuant to the Agreement and Plan of Merger dated as of September 21, 2023 (the "Merger Agreement"), by and among Cyclo Therapeutics, Inc. ("Cyclo"), Cameo Merger Sub, Inc. and the Issuer, at the effective time of the merger, each outstanding option with an exercise price of $0.40 or more was cancelled effective as of the closing.
- [F2]Pursuant to the terms of the Merger Agreement, this option was exchanged for an option covering 2,662 shares of Cyclo Common Stock.
Documents
Issuer
Applied Molecular Transport Inc.
CIK 0001801777
Entity typeother
Related Parties
1- filerCIK 0001559583
Filing Metadata
- Form type
- 4
- Filed
- Dec 27, 7:00 PM ET
- Accepted
- Dec 28, 5:38 PM ET
- Size
- 10.4 KB